Indian Biotechnology Market Outlook (2006)

Indian Biotechnology Market Outlook (2006)

The report “Indian Biotechnology Market Outlook (2006)” provides an updated and detailed overview of the Indian Biotechnology industry. It examines the emerging trends and provides exclusive forecasts and segment-wise snapshots of biotechnology industry in India. Report also highlights the information regarding Biotech parks in India and region-wise Biocluster.

Key Findings

§ Growing at the rate of 28.09% from the year 2005, Indian Biotechnology industry is likely to touch the mark of US$ 5 Billion by the end of 2010.
§ India will emerge as a key destination for clinical trials & stem cell research.
§ Biotechnology will play an important role in Agriculture sector by developing large number of genetically modified crops.
§ BioPharma industry, comprising of vaccines, therapeutics and other products, will emerge as major segment of Indian Biotech industry.

Key Issues and Facts Analyzed

The research report also addresses the issues and facts that are critical to your success:

§ What are the market trends in the Indian Biotechnology industry?
§ Where the market will be after 5 years?
§ What opportunities exist in Indian Biotechnology industry?
§ What are the driving factors for the Indian Biotechnology industry?
§ What are the challenges faced by Biotechnology industry?
§ Who are the main players in the Indian Biotechnology industry?

Key Players Analyzed

This section provides the overview and key financial information of prominent players in the Indian Biotechnology Industry, like Biocon, Serum Institute of India, Nicholas Piramal India Limited (NPIL), Wockhardt Limited, GlaxoSmithKline, Bharat Serums and Vaccines (BSV), Zydus Cadila, Indian Immunologicals Limited (IIL), Krebs Biochemical’s & Industries Limited (KBIL), Novo Nordisk, Mahyco Monsanto, Bharat Biotech, Abbott, Ranbaxy, Novozymes etc.

Research Methodology Used

Information Sources
Information has been sourced from books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods
The analysis methods includes the following: Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis using software tools, Judgmental Forecasting and Cause and Effect Analysis.

1. Analyst View
2. Research Overview
3. Biotechnology Industry Overview
3.1 Biotechnology Industry - Worldwide
3.2 Biotechnology Industry - Asia-Pacific
3.3 Biotechnology Industry - India
4. Indian Biotechnology Industry Performance
4.1 Market Size
4.2 Biotech Domestic and Exports Market
4.3 Biotech Market Segmentation
4.3.1 Biopharmaceuticals
4.3.2 BioServices (Contract Research)
4.3.3 Agri Biotech
4.3.4 Industrial Biotech
4.3.5 Bioinformatics
4.4 Biotech Parks
4.4.1 Shapoorji Pallonji Biotech Park
4.4.2 ICICI Knowledge Park
4.4.3 International Biotech Park
4.4.4 Lucknow Biotech Park
4.4.5 Ticel Bio Park
4.4.6 Upcoming Parks
4.5 Investments in Indian Biotechnology Sector
4.6 Employment Opportunities in Biotech Sector
4.7 National Biotechnology Development Strategy
5. Indian Bio-Clusters
5.1 Southern Region
5.1.1 Andhra Pradesh - The Hyderabad Bio-Cluster
5.1.2 Karnataka - The Bangalore Bio-Cluster
5.1.3 Tamil Nadu - The Chennai Bio-Cluster
5.1.4 Kerala
5.2 Western Region
5.2.1 Maharashtra - The Pune Bio-Cluster
5.2.2 Gujarat
5.3 Northern Region
5.3.1 Uttar Pradesh - Lucknow
5.3.2 Punjab
6. Industry Analysis
6.1 Key Driving Forces
6.1.1 Human Resources
6.1.2 Strong Bio-processing Skills
6.1.3 Bio-diversity
6.1.4 Regulatory Framework
6.2 Opportunity
6.2.1 Outsourcing of Preliminary Research
6.2.2 Off-patent Drug
6.2.3 Clinical Trial Opportunity
6.2.4 Bioinformatics
6.2.5 Stem Cell Research
6.2.6 Agricultural Biotechnology
6.2.7 Biofuel
6.2.8 Biofertilizers/BioPesticides
6.3 Challenges
6.3.1 Lack of IPR (Intellectual Property Rights) Regime
6.3.2 Time to Market
6.3.3 Seed Funding
6.3.4 Synergy between Stakeholders
6.3.5 High Innovative Drug Cost
6.3.6 Regulatory Issues
6.4 Future Outlook, 2010
7. Key Players and Company Profiles
7.1 Biotech Suppliers
7.2 Biotech Companies
7.3 Company Profiles
7.3.1 Biocon
7.3.2 Serum Institute of India
7.3.3 Panacea Biotech
7.3.4 Nicholas Piramal India Limited (NPIL)
7.3.5 Wockhardt Limited
7.3.6 GlaxoSmithKline
7.3.7 Bharat Serums and Vaccines (BSV)
7.3.8 Krebs Biochemical’s & Industries Limited (KBIL)
7.3.9 Zydus Cadila
7.3.10 Indian Immunologicals Limited (IIL)
7.3.11 Shantha Biotechnics
7.3.12 Biological E
7.3.13 Chiron Behring Vaccines
7.3.14 Eli Lilly
7.3.15 Novo Nordisk
7.3.16 Mahyco Monsanto
7.3.17 Bharat Biotech
7.3.18 Abbott
7.3.19 Ranbaxy
7.3.20 Novozymes
8. Annexure I: Government Initiatives and Regulations
8.1 Fiscal Incentives Provided to the Biotech Sector
8.1.1 Tax
8.1.2 Regulatory
8.1.3 Investment
8.2 Important Changes to the Patents Act in the Third Amendment Bill
8.2.1 Substantive Changes
8.2.2 Procedural Changes
8.3 Plant Varieties and Farmers’ Rights Protection Act, 2001
8.4 Other Regulations impacting the Biotech Sector
8.4.1 Licensing
8.4.2 Clinical Trials
8.4.3 Seeds Act and Policy
8.4.4 Environmental Clearances
8.4.5 Biological Diversity Act

List of Figures:

Figure 3-1: Worldwide - Biotechnology Market (in Billion US$), 2001-2006E
Figure 3-2: Worldwide - Biotechnology Market Share by Region (%), 2005
Figure 3-3: Worldwide - Biotechnology Market Share by Segment (%), 2005
Figure 3-4: Worldwide - Forecast for Biotechnology Market (in Billion US$), 2007-2010
Figure 3-5: Asia-Pacific - Biotechnology Market (in Billion US$), 2001-2005
Figure 3-6: Asia-Pacific - Biotechnology Market Share by Region (%), 2005
Figure 3-7: Asia-Pacific - Biotechnology Market Share by Segment (%), 2005
Figure 3-8: Asia-Pacific - Forecast for Biotechnology Market (in Billion US$), 2006-2010
Figure 3-9: India - Budget Allocations of Major Biotechnology Funding Agencies (in Million US$), 1990-91, 2000-01, 2002-03 to 2004-05
Figure 4-1: India - Biotechnology Industry Revenue Growth (in Million US$), 2002-03 to 2005-06
Figure 4-2: India - Market Size of Biotech Industry (in Million US$), 2003-04 to 2005-06
Figure 4-3: India - Biotechnology Market Share by Segment (%), 2004-05 & 2005-06
Figure 4-4: India - Domestic Market and Exports Market of Biotech Industry (%), 2005-06
Figure 4-5: India - Biotech Exports Market Segment (%), 2004-05 & 2005-06
Figure 4-6: India - Biotech Domestic Market Segment (%), 2004-05 & 2005-06
Figure 4-7: India - Biotech Domestic Market (in Million US$), 2005-06
Figure 4-8: India - Bioipharma Segment (%), 2004-05 & 2005-06
Figure 4-9: India - Revenues from BioPharma (in Million US$), 2004-05 & 2005-06
Figure 4-10: India - Recombinant Therapeutics Products Market (in Million US$), 2005-06
Figure 4-11: India - Market Share of BioServices Companies (in Rs Crore), 2005-06
Figure 4-12: India - Agri Biotech Components’ Market (%), 2004-05
Figure 4-13: India - BT Cotton Seeds Revenues (in Rs Crore), 2003-04 & 2004-05
Figure 4-14: India - Industrial Biotech Market (in Million US$), 2003-04 to 2005-06
Figure 4-15: India - Bio-Industrial Companies Revenue (in Million US$), 2003-04 & 2004-05
Figure 4-16: India - Industrial Biotech Share by Sector (%), 2005-06
Figure 4-17: India - Growth in Revenue of Major BioIndustrial Firms (%), 2003 to 2005
Figure 4-18: India - Bioinformatics Market (in Million US$), 2003-04 to 2006-07E
Figure 4-19: India - Investments in Biotech Industry (in Million US$), 2000-01 to 2005-06
Figure 4-20: India - Total Manpower in Biotech Sector (in Numbers), 2002-03 to 2004-05
Figure 4-21: India - Human Resource Allocation in Biotech Sector (%), 2006
Figure 5-1: India - Revenue of Biotech Industry by Region (%), 2005-06
Figure 6-1: India - Forecast for Biotechnology Industry (in Billion US$), 2006-2010
Figure 7-1: India - Revenue of Top 20 Bio-Suppliers by Region (%), 2004-05

List of Tables:

Table 4-1: India - Segment-wise Exports of Biotech Industry (in Million US$), 2005-06
Table 4-2: India - BT Cotton Sales (in Packets), 2003-2005
Table 4-3: India - Permitted BT Cotton Seeds
Table 7-1: India - Revenue of Top 20 Bio-Suppliers (in Rs Crore), 2003-04 & 2004-05
Table 7-2: India - Top 20 Biotech Companies by Revenue (in Rs. Crore), 2005-06
Table 7-3: Top 20 Biotech Companies of Indian Origin by Revenue (in Rs. Crore), 2004-05 & 2005-06
Table 7-4: Biocon - Key Financials (in Million Rs), 2004-05 & 2005-06
Table 7-5: Panacea Biotech - Key Financials (in Million Rs), 2004-05 & 2005-06
Table 7-6: Nicholas Piramal India Limited - Key Financials (in Million Rs), 2004 &2005
Table 7-7: Wockhardt Limited - Key Financials (in Billion Rs), 2004 & 2005
Table 7-8: GlaxoSmithKline - Key Financials (in Million US$), 2004 & 2005
Table 7-9: Krebs Biochemical’s & Industries Limited - Key Financial (in Million US$), 2004-05 & 2005-06
Table 7-10: Abbott - Key Financial (in Million Rs), May 2006
Table 7-11: Ranbaxy - Key Financials (in Million Rs), 2005